BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35366820)

  • 1. Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts.
    Jones A; Saini J; Kriel B; Via LE; Cai Y; Allies D; Hanna D; Hermann D; Loxton AG; Walzl G; Diacon AH; Romero K; Higashiyama R; Liu Y; Berg A
    BMC Infect Dis; 2022 Apr; 22(1):327. PubMed ID: 35366820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria.
    Wood R; Racow K; Bekker LG; Middelkoop K; Vogt M; Kreiswirth BN; Lawn SD
    BMC Infect Dis; 2012 Feb; 12():47. PubMed ID: 22369353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, radiological, and laboratory predictors of a positive urine lipoarabinomannan test in sputum-scarce and sputum-negative patients with HIV-associated tuberculosis in two Johannesburg hospitals.
    Chernick L; Kalla IS; Venter M
    South Afr J HIV Med; 2021; 22(1):1234. PubMed ID: 34394971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
    Azam K; Khosa C; Viegas S; Massango I; Bhatt N; Jani I; Heinrich N; Hoelscher M; Gillespie SH; Rachow A; Sabiiti W
    Front Immunol; 2022; 13():1005692. PubMed ID: 36189292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of chemiluminescence for urinary lipoarabinomannan antigen assay in active tuberculosis: insights from a retrospective study.
    Huang L; Niu Y; Zhang L; Yang R; Wu M
    Front Cell Infect Microbiol; 2023; 13():1291974. PubMed ID: 38145052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
    Broger T; Nicol MP; Székely R; Bjerrum S; Sossen B; Schutz C; Opintan JA; Johansen IS; Mitarai S; Chikamatsu K; Kerkhoff AD; Macé A; Ongarello S; Meintjes G; Denkinger CM; Schumacher SG
    PLoS Med; 2020 May; 17(5):e1003113. PubMed ID: 32357197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
    BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
    BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study.
    Kebede W; Abebe G; Gudina EK; Van Rie A
    Sci Rep; 2021 Dec; 11(1):24428. PubMed ID: 34952913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study.
    Bjerrum S; Kenu E; Lartey M; Newman MJ; Addo KK; Andersen AB; Johansen IS
    BMC Infect Dis; 2015 Oct; 15():407. PubMed ID: 26427365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine.
    De P; Amin AG; Valli E; Perkins MD; McNeil M; Chatterjee D
    PLoS One; 2015; 10(12):e0144088. PubMed ID: 26633829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved algorithm for rapid diagnosis of pleural tuberculosis from pleural effusion by combined testing with GeneXpert MTB/RIF and an anti-LAM antibody-based assay.
    Liang Q; Pang Y; Yang Y; Li H; Guo C; Yang X; Chen X
    BMC Infect Dis; 2019 Jun; 19(1):548. PubMed ID: 31226940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.